Skip to content

Gene regulatory networkand development of clinical early diagnostic markers of preeclampsia

Gene regulatory networkand development of clinical early diagnostic markers of preeclampsia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044327
Enrollment
Unknown
Registered
2021-03-16
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclmapsia

Interventions

Normal group:Nil
preeclampsia:Nil

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of normal group: Normal pregnant women refer to natural pregnancy, normal full-term pregnant women, refers to those who do not have any complications and give birth to live infants without abnormal phenotype. Inclusion criteria of preeclampsia group: Mild PE pregnant women group (l-pe): systolic blood pressure >= 140 mmHg and / or diastolic blood pressure >= 90 mmHg after 20 weeks of gestation, accompanied by any of the following: urinary protein >= 0.3 g/24 h. Or urinary protein / creatinine ratio >=0.3, or random urinary protein >= (+) (the examination method when the urinary protein can not be quantified); no proteinuria but with any of the following organs or systems involved: heart, lung, liver, kidney and other important organs, or abnormal changes in the blood system, digestive system, nervous system, placenta fetus involved, etc. Severe PE pregnant women group (s-pe): PE pregnant women with any of the following symptoms can be diagnosed as s-pe: (1) continuous increase of blood pressure: systolic blood pressure >= 160 mmHg and / or diastolic blood pressure >= 110 mmHg MmHg; (2) persistent headache, visual impairment or other abnormalities of the central nervous system; (3) persistent upper abdominal pain and liver subcapsular hematoma or liver rupture; (4) abnormal liver enzymes: elevated serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST); (5) impaired renal function: urinary protein > 2.0g/24 h; oliguria (24 h urine volume < 400); (6) hypoproteinemia with ascites, pleural effusion or pericardial effusion; (7) abnormal blood system: the platelet count decreased continuously and was lower than 0 The results showed that the blood lactate dehydrogenase (LDH) level 100x10^9/L; microvascular hemolysis [anemia, jaundice or increased LDH level]; (8) heart failure; (9) pulmonary edema; (10) fetal growth restriction or oligohydramnios, intrauterine fetal death, placental abruption, etc.

Exclusion criteria

Exclusion criteria: Exclusion criteria for normal group: pregnancy injury (fetal malformation, abortion, premature birth, trophoblastic disease, etc.); twin and multiple pregnancies; high risk pregnancy complications (GDM); individuals taking drugs (especially aspirin, antibiotics), alcohol intake, individuals with risk factors, such as obesity, primary cardiovascular disease, liver and kidney disease, systemic lupus erythematosus, etc.

Design outcomes

Primary

MeasureTime frame
cell types;

Countries

China

Contacts

Public ContactYanwei Hu

Guangzhou Women and Children's Medical Center

ywhu0618@163.com+86 020-38837721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026